Nektar TherapeuticsNKTRNASDAQ
Loading
Interest Expense Over TimeStable
Percentile Rank14
3Y CAGR-3.2%
5Y CAGR-6.7%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-3.2%/yr
vs -9.3%/yr prior
5Y CAGR
-6.7%/yr
Recent acceleration
Acceleration
+6.1pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $26.18M | -6.9% |
| 2024 | $28.11M | +11.0% |
| 2023 | $25.33M | -12.4% |
| 2022 | $28.91M | -38.9% |
| 2021 | $47.31M | +27.5% |
| 2020 | $37.12M | -19.9% |
| 2019 | $46.35M | +8.4% |
| 2018 | $42.78M | +4.5% |
| 2017 | $40.95M | -2.9% |
| 2016 | $42.18M | - |